The long-term survival rate for women diagnosed with ductal carcinoma in situ (DCIS) or non-invasive breast cancer is excellent, according to a new study released in August. The study, “Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ” revealed that this held true regardless of the type of treatment. […]
In true Hollywood fashion, when a celebrity speaks the masses listen.
Quickly dubbed the “Angelina Jolie Effect,” the number of women requesting a blood test to reveal if they’re carriers of the BRCA1 and BRCA2 genes has nearly doubled since the editorial’s 2013 publication, according to various studies including one by the online journal Breast Cancer Research.
Although inherited factors account for less than 5 percent of breast cancer cases, individuals […]
Many breast cancer patients are unfamiliar with basic information about their disease. Researchers who recently surveyed patients regarding tumor stage, grade and hormone receptor status were surprised by the amount of women without accurate knowledge of these cancer characteristics. Without information about their condition, women miss out on opportunities to improve their health and outcomes.
Do Breast Cancer Patients Understand Their Disease?
Few studies have investigated whether women with breast cancer understand specific details about their cancer. In a survey of 500 women, researchers from the Dana-Farber Cancer Institute in Boston sought to find out how much women actually know about their disease. Results were published in the January 2015 issue of […]
A recent study revealed great news for women facing early-stage invasive breast cancer: choosing to preserve some breast tissue rather than removing the entire breast isn’t inviting more risk.
Survival Rate is Higher with Lumpectomy vs Mastectomy
Even when coupled with various factors – age, socioeconomic status, race, tumor grade, proportion of positive nodes and year of diagnosis – women were less likely to die with a lumpectomy.
For decades, the two […]
Part of my commitment to deliver the highest quality and most advanced care to patients is to explore cutting-edge breast cancer techniques and treatments. I’m excited to share with the Breastlink community that we completed our first intraoperative radiotherapy (IORT) procedure, using the XOFT Axxent® eBx System.
IORT is a relatively new approach to deliver radiotherapy in conjunction with a lumpectomy. During the surgical procedure, and after the identified breast cancer has been removed, an individualized dose of radiation therapy is specifically targeted to the immediate area around where the cancer was located.
Image courtesy of Xoft.